| Pharmacology of adenosine receptors: the state of the art PA Borea, S Gessi, S Merighi, F Vincenzi, K Varani Physiological reviews 98 (3), 1591-1625, 2018 | 711 | 2018 |
| Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects? PA Borea, S Gessi, S Merighi, K Varani Trends in pharmacological sciences 37 (6), 419-434, 2016 | 317 | 2016 |
| The A3 adenosine receptor: an enigmatic player in cell biology S Gessi, S Merighi, K Varani, E Leung, S Mac Lennan, PA Borea Pharmacology & therapeutics 117 (1), 123-140, 2008 | 287 | 2008 |
| A glance at adenosine receptors: novel target for antitumor therapy S Merighi, P Mirandola, K Varani, S Gessi, E Leung, PG Baraldi, ... Pharmacology & therapeutics 100 (1), 31-48, 2003 | 278 | 2003 |
| The A3 adenosine receptor: history and perspectives PA Borea, K Varani, F Vincenzi, PG Baraldi, MA Tabrizi, S Merighi, ... Pharmacological reviews 67 (1), 74-102, 2015 | 275 | 2015 |
| Adenosine receptors and cancer S Gessi, S Merighi, V Sacchetto, C Simioni, PA Borea Biochimica et Biophysica Acta (BBA)-Biomembranes 1808 (5), 1400-1412, 2011 | 253 | 2011 |
| Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1α, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer … S Merighi, A Benini, P Mirandola, S Gessi, K Varani, C Simioni, E Leung, ... Molecular pharmacology 72 (2), 395-406, 2007 | 208 | 2007 |
| Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells S Merighi, P Mirandola, D Milani, K Varani, S Gessi, KN Klotz, E Leung, ... Journal of Investigative Dermatology 119 (4), 923-933, 2002 | 199 | 2002 |
| A2A adenosine receptors in human peripheral blood cells S Gessi, K Varani, S Merighi, E Ongini, PA Borea British journal of pharmacology 129 (1), 2, 2000 | 193 | 2000 |
| Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils K Varani, S Gessi, S Merighi, V Iannotta, E Cattabriga, S Spisani, ... British journal of pharmacology 136 (1), 57-66, 2002 | 181 | 2002 |
| [3H] MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors K Varani, S Merighi, S Gessi, KN Klotz, E Leung, PG Baraldi, B Cacciari, ... Molecular Pharmacology 57 (5), 968-975, 2000 | 177 | 2000 |
| A3 Adenosine Receptor Ligands: History and Perspectives PG Baraldi, B Cacciari, R Romagnoli, S Merighi, K Varani, PA Borea, ... Medicinal research reviews 20 (2), 103-128, 2000 | 177 | 2000 |
| A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study S Gessi, K Varani, S Merighi, E Cattabriga, V Iannotta, E Leung, ... Molecular pharmacology 61 (2), 415-424, 2002 | 157 | 2002 |
| Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields K Varani, M De Mattei, F Vincenzi, S Gessi, S Merighi, A Pellati, A Ongaro, ... Osteoarthritis and Cartilage 16 (3), 292-304, 2008 | 155 | 2008 |
| Dose and Time Effects of Caffeine Intake on Human Platelet Adenosine A2A Receptors: Functional and Biochemical Aspects K Varani, F Portaluppi, S Gessi, S Merighi, E Ongini, L Belardinelli, ... Circulation 102 (3), 285-289, 2000 | 155 | 2000 |
| Pulsed Electromagnetic Fields Increased the Anti-Inflammatory Effect of A2A and A3 Adenosine Receptors in Human T/C-28a2 Chondrocytes and hFOB 1.19 … F Vincenzi, M Targa, C Corciulo, S Gessi, S Merighi, S Setti, R Cadossi, ... PloS one 8 (5), e65561, 2013 | 153 | 2013 |
| A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy KA Jacobson, S Merighi, K Varani, PA Borea, S Baraldi, ... Medicinal research reviews 38 (4), 1031-1072, 2018 | 151 | 2018 |
| Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells S Merighi, A Benini, P Mirandola, S Gessi, K Varani, E Leung, ... Biochemical pharmacology 72 (1), 19-31, 2006 | 151 | 2006 |
| Medicinal chemistry, pharmacology, and clinical implications of TRPV1 receptor antagonists M Aghazadeh Tabrizi, PG Baraldi, S Baraldi, S Gessi, S Merighi, ... Medicinal research reviews 37 (4), 936-983, 2017 | 142 | 2017 |
| A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 … S Merighi, A Benini, P Mirandola, S Gessi, K Varani, E Leung, ... Journal of Biological Chemistry 280 (20), 19516-19526, 2005 | 142 | 2005 |
Borea Pier Andrea universita' di Ferrar...University of FerraraVerified email at unife.it
